Jefferies Likes 4 Beaten-Down Growth Stocks Now

March 29, 2016 by Lee Jackson

In a market where earnings growth is getting harder to find, many on Wall Street are quick to pull the trigger if an earnings report falls short or some other headline issues causes selling. The fact of the matter is that most solid growth companies occasionally will have a hiccup, and when they do the stock will get sold off for little or no reason. That’s the time for savvy investors to swoop in and accumulate shares.

Jefferies recent “Picturing the Week’s Opportunities” research piece focuses on large cap growth stocks that are very solid but have taken a hit either from earnings disappointment or an event-driven issue. All make good sense for growth stock investors looking for value, and all are rated Buy at Jefferies.

Acadia Healthcare

This company could have a revenue explosion over the next three years if the Jefferies team is right. Acadia Healthcare Co. Inc. (NASDAQ: ACHC) is a provider of in-patient behavioral health services. Acadia operates a network of 226 facilities with approximately 9,200 beds in 37 states, the United Kingdom and Puerto Rico. Acadia provides psychiatric and chemical dependency services to its patients in a variety of settings, including in-patient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs.

The company posted stellar earnings last year, and Jefferies thinks that its revenues can double in three years, owing to not only strong organic growth, but potential acquisitions. Also cited in the past was that analysts believe political support for expanded Medicaid coverage for adult mental health could grow the company’s addressable market by up to 30%.

Acadia reported strong results in February, with 8% same-store sales gains, and the analysts noted that while guidance was below expectations, they think the company is being extremely conservative, and there is a degree of currency headwinds to account for, in addition to a recent equity offering. They also noted that 40% of EBITDA is from the United Kingdom, and concerns over the country leaving the European union have also weighed on shares.

The Jefferies price target for the stock is $85, and the Thomson/First Call consensus target is $78.31. The stock closed Monday at $53.45.